期刊
REDOX BIOLOGY
卷 55, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.redox.2022.102395
关键词
Lung cancer; Lung adenocarcinoma; Non-small cell lung cancer; 2-Methoxyestradiol; Estrogen metabolites; Biomarker; Blood serum; Molecular modeling; electrophilic potential
资金
- Medical University of Gdansk, Gdansk, Poland [71-1203]
2-Methoxyestradiol (2-ME) as an inhibitor for non-small cell lung cancer cells may serve as a potential therapeutic approach, reducing cell viability, promoting protein palmitoylation and oxidative stress, and showing relative safety in healthy human cells compared to other estrogen metabolism intermediates.
Lung cancer is one of the most common cancers worldwide, causing nearly one million deaths each year. Herein, we present the effect of 2-methoxyestradiol (2-ME), the endogenous metabolite of 17 beta-estradiol (E2), on nonsmall cell lung cancer (NSCLC) cells. We observed that 2-ME reduced the viability of lung adenocarcinoma in two-dimensional (2D) and three-dimensional (3D) spheroidal A549 cell culture models. Molecular modeling was carried out aiming to visualize amino acid residues within binding pockets of the acyl-protein thioesterases, namely 1 (APT1) and 2 (APT2), and thus to identify which ones were more likely involved in the interaction with 2-ME. Our findings suggest that 2-ME acts as an APT1 inhibitor enhancing protein palmitoylation and oxidative stress phenomena in the lung cancer cell. In order to support our data, metabolomics of blood serum from NSCLC patients was also performed. Moreover, computational analysis suggests that 2-ME as compared to other estrogen metabolism intermediates is relatively safe in terms of its possible non-receptor bioactivity within healthy human cells due to a very low electrophilic potential and hence no substantial risk of spontaneous covalent modification of biologically protective nucleophiles. We propose that 2-ME can be used as a selective tumor biomarker in the course of certain types of lung cancers and possibly as a therapeutic adjuvant or neoadjuvant.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据